Vascular Solutions
Endovascular procedure planning module for vascular interventions
Software · Cloud SaaSCompany source
Company profile
About Therenva SAS
Therenva SAS creates innovative medical software devices designed to help physicians and healthcare professionals perform efficient cardiovascular procedures. The company offers two flagship products: EndoSize, an AI-based software for endovascular procedure planning that enables physicians to fully plan cases in minutes and control treatment strategies and device placement; and EndoNaut, a unique image fusion and navigation system compatible with any C-arm that provides real-time guidance during procedures. Both products embed cutting-edge data processing algorithms, including AI, deep learning, and biomechanical simulation. EndoSize includes specialized modules for vascular procedures, TAVI/TAVR, and TMVR treatments, featuring automatic AI-based valve segmentation. EndoNaut has been clinically proven to significantly reduce radiation dose and contrast agent volume by over 30% during EVAR procedures. The company's solutions are designed to bridge the gap between fixed and mobile imaging systems in vascular surgery, offering integrated navigation technology natively available in mobile C-arm interfaces through partnerships with imaging equipment manufacturers like Ziehm Imaging. Therenva serves vascular surgeons, interventional cardiologists, and healthcare facilities performing minimally invasive cardiovascular interventions across Europe, the United States, and expanding international markets.
Company description Therenva SAS official website
Primary marketSurgical AI & Robotics
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Therenva SAS?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- aorto-iliac interventions
- endovascular procedures
- EVAR
- peripheral vascular procedures
- structural heart disease
- TAVI/TAVR
- TMVR
Who it serves
- Hospitals
- Hybrid Operating Rooms
- Interventional Cardiology Departments
- Vascular Surgery Departments
Deployment & integration
Cloud Saas · Embedded deployment with recorded integration context.
Recorded integration context: mobile C-arm systems, Ziehm Imaging C-arms.
Geographic context
MarketsAustria · Europe · France · Germany · Romania · Spain · Switzerland · United Kingdom · United States
Company sourceOfficial website
Company milestones
Platform expansion
First-ever image fusion technology natively integrated into mobile C-arm (Ziehm). EndoNaut installed in Romania's first mobile hybrid suite at Bucharest Sanador Clinic. Launch of AI-powered EndoSize Cardio modules for TAVI and TMVR with automatic valve segmentation.
Partnerships
Recorded partners
- Ziehm France
- Ziehm Imaging
- Ziehm Spain
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
EndoNaut
Fusion imaging and navigation system compatible with any C-arm for intra-operative guidance
Software · EmbeddedCompany source
EndoNaut Aorto-iliac
Navigation solution for aorto-iliac endovascular procedures
Software · EmbeddedCompany source
EndoNaut Peripheral
Navigation solution for peripheral endovascular interventions
Software · EmbeddedCompany source
EndoSize
AI-based endovascular procedure planning software for vascular and structural heart interventions
Software · Cloud SaaSCompany source
EndoSize Structural Heart
AI-based structural heart planning software for TAVI/TAVR and TMVR procedures
Software · Cloud SaaSCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
EndoNaut two-dimensional fusion imaging with a mobile C-arm for endovascular treatment of occlusive peripheral arterial disease.Journal of vascular surgery · Feb 1, 2022
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
EndoNautK222070 · 510k · Oct 25, 2022
EndoNautK212383 · 510k · Aug 31, 2021
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
>30% reduction in radiation dose
EVAR procedures with EndoNaut navigation
>30% reduction in contrast agent volume
EVAR procedures with EndoNaut navigation
No compromise in technical success or procedural time
EVAR procedures using navigation system
Bordeaux University Hospital / Libourne Hospital
Reduction in radiation dose and contrast agent volume during EVAR procedures using EndoNaut navigation system
>30% reduction in radiation dose and contrast agent volume in 250+ patients
Bucharest Sanador Clinic
Romania's first mobile hybrid suite implementation with EndoNaut for endovascular surgery
CHUV Lausanne
Clinical experience with EndoNaut navigation system and Ziehm RFD HE for endovascular procedures
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from Therenva SAS
Recent articles published on Therenva SAS's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Surgical AI & Robotics
Companies developing surgical technologies enhanced by AI, including robotic surgical systems, AI-powered surgical assistance and navigation tools, autonomous surgical robotics, and surgical data and analytics platforms. Covers both the performance of surgery and the analysis of surgical outcomes and OR efficiency.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.